A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

Cited by (1,000)

Items 701–800 of 1,000

1. Calcitriol in the Presence of Conditioned Media from Metastatic Breast Cancer Cells Enhances Ex Vivo Polarization of M2 Alternative Murine Bone Marrow-Derived Macrophages
   Artur Anisiewicz, Natalia Łabędź, Izabela Krauze, Joanna Wietrzyk · 2020 · Cancers
2. Multi-omics characterization and validation of invasiveness-related molecular features across multiple cancer types
   Guoshu Bi, Jiaqi Liang, Yuansheng Zheng, Runmei Li, Mengnan Zhao, Yiwei Huang, Cheng Zhan, Songtao Xu, Hong Xia Fan · 2021 · Journal of Translational Medicine
3. Reversal of Human Multi‐Drug Resistance Leukaemic Cells by Stemofoline Derivatives via Inhibition of P‐Glycoprotein Function
   Sonthaya Umsumarng, Pornsiri Pitchakarn, Kwankamol Sastraruji, Supachai Yodkeeree, Alison Thavary Ung, Stephen G. Pyne, Pornngarm Limtrakul · 2014 · Basic & Clinical Pharmacology & Toxicology
4. Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions
   Amanda Valeta-Magara, Raheleh Hatami, Deborah Axelrod, Daniel F. Roses, Amber Azniv Guth, Silvia Chiara Formenti, Robert J. Schneider · 2015 · SpringerPlus
5. Arresting supporters: targeting neutrophils in metastasis
   Swarnali Acharyya, Joan Massagué · 2016 · Cell Research
6. Bacteroides Fragilis Toxin Coordinates a Pro-Carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells
   Liam Chung, Erik Thiele Orberg, Abby L. Geis, June L. Chan, Kai Fu, Christina E. DeStefano Shields, Christine M. Dejea, Payam Fathi, Jie Chen, Benjamin B. Finard et al. · 2018 · SSRN Electronic Journal
7. Engineering perfusion to meet tumor biology: are vascularized tumor-on-a-chip models ready to drive therapy innovation?
   Ines Poljak, Ciro Chiappini, Giulia Adriani · 2026 · Lab on a Chip
8. HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
   Xudong Zhu, Yixiao Zhang, Yang Bai, Xi Gu, Guanglei Chen, Lisha Sun, Yulun Wang, Xinbo Qiao, Qingtian Ma, Tong Zhu et al. · 2020 · International Journal of Medical Sciences
9. Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer
   Victor Oginga Oria, Janine Terra Erler · 2023 · Cells
10. RETRACTED ARTICLE: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin
    Laura Damiano, Kathleen M. Stewart, Nathalie Cohet, Janna K. Mouw, Jonathon N. Lakins, Jayanta Debnath, David Reisman, Jeffrey A. Nickerson, Anthony N. Imbalzano, Valerie Marie Weaver · 2013 · Oncogene · Retracted
11. Persistent effects of Libby amphibole and amosite asbestos following subchronic inhalation in rats
    Stephen H. Gavett, Carl U. Parkinson, Gabrielle A. Willson, Charles E. Wood, Annie M. Jarabek, Kay C. Roberts, Urmila P. Kodavanti, Darol E. Dodd · 2015 · Particle and Fibre Toxicology
12. LPA5-mediated signaling induced by endothelial cells and anticancer drug regulates cellular functions of osteosarcoma cells
    Kanako Minami, Nanami Ueda, Kaichi Ishimoto, Toshifumi Tsujiuchi · 2020 · Experimental Cell Research
13. Basic fibroblast growth factor promotes doxorubicin resistance in chondrosarcoma cells by affecting XRCC5 expression
    Ming‐Ju Hsieh, Cheng Huang, Chia‐Chieh Lin, Chih‐Hsin Tang, Chih‐Yang Lin, I‐Neng Lee, Hsiu‐Chen Huang, Jui‐Chieh Chen · 2020 · Molecular Carcinogenesis
14. Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment
    Eric Freund, Chiara Spadola, Anke Schmidt, Angela Privat‐Maldonado, Annemie Bogaerts, Thomas von Woedtke, Klaus‐Dieter Weltmann, Claus-Dieter Heidecke, Lars-Ivo Partecke, André Käding et al. · 2020 · Frontiers in Physics
15. Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses
    Qiyuan Lv, Haizhou Zou, Yuyan Xu, Zhenyong Shao, Ruoqi Wu, Kejie Li, Xia Deng, Dian-na Gu, Hong-xiao Jiang, Meng Su et al. · 2021 · Bioengineered
16. Diverse roles of tumor-stromal PDGFB-to-PDGFRβ signaling in breast cancer growth and metastasis
    Sajita Shah, Gina M. Sizemore · 2022 · Advances in cancer research
17. Regulatory T cells crosstalk with tumor cells and endothelium through lymphotoxin signaling
    Wenji Piao, Long Wu, Yanbao Xiong, Gregory Zapas, Christina Paluskievicz, Robert S. Oakes, Sarah M. Pettit, Margaret L. Sleeth, Keli Lee Hippen, Jessica Schmitz et al. · 2024 · Nature Communications
18. Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration
    Freeha Khalid, Kiyoshi Takagi, Ai Sato, M. Yamaguchi, Fouzia Guestini, Yasuhiro Miki, Minoru Miyashita, Hisashi Hirakawa, Yasuyo Ohi, Yoshiaki Rai et al. · 2023 · Breast Cancer
19. Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors
    Jiawei Fan, Jianshu Zhu, He Zhu, Hong Xu · 2024 · Critical Reviews in Oncology/Hematology
20. Impact of STAT-signaling pathway on cancer-associated fibroblasts in colorectal cancer and its role in immunosuppression
    Damián Sánchez-Ramírez, Mónica Mendoza-Rodríguez, Omar Rafael Alemán, Fernando Candanedo-González, Miriam Rodríguez‐Sosa, Juan José Montesinos, Mauricio Salcedo, Ismael Brito-Toledo, Felipe Vaca‐Paniagua, Luis Ignacio Terrazas · 2024 · World Journal of Gastrointestinal Oncology
21. Crosstalk between cancer cells and macrophages promotes OSCC cell migration and invasion through a CXCL1/EGF positive feedback loop
    Wei Huang, Mingjing Jiang, Ying Lin, Ying Qi, Bo Li · 2024 · Discover Oncology
22. Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment
    Hideyuki Masui, Kenji Kawada, Yoshiro Itatani, Hideyo Hirai, Yuki Nakanishi, Yoshiyuki Kiyasu, Keita Hanada, Michio T. OKAMOTO, Wataru Hirata, Yasuyo Nishikawa et al. · 2024 · British Journal of Cancer
23. Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review
    Manu Yadav, Ishita Vaishkiar, Ananya Sharma, Akanksha Shukla, Aradhana Mohan, Madhuri Girdhar, Anil Kumar, Tabarak Malik, Anand Mohan · 2024 · Open Biology
24. Multifaceted roles of neutrophils in tumor microenvironment
    Xue‐Yin Pan, Qiang Wang, Beicheng Sun · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
25. Characterization of Aurora A and Its Impact on the Effect of Cisplatin-Based Chemotherapy in Patients with Non–Small Cell Lung Cancer
    Peng Kuang, Zuhua Chen, Jiayuan Wang, Zhentao Liu, Jingyuan Wang, Jing Gao, Lin Shen · 2017 · Translational Oncology
26. Effective Combinations of Radiotherapy and Immunotherapy in the Treatment of Esophageal Squamous Cell Carcinoma
    Yang Yang, Hong Ge · 2020 · Future Oncology
27. MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin
    Jui‐Chieh Chen, Hsun-Chang Shih, Chih‐Yang Lin, Jeng‐Hung Guo, Cheng Huang, Hsiu‐Chen Huang, Zhi-Yong Chong, Chih‐Hsin Tang · 2023 · International Journal of Molecular Sciences
28. Secreted amphiregulin promotes vincristine resistance in oral squamous cell carcinoma
    Ming‐Ju Hsieh, Yin‐Hong Chen, I‐Neng Lee, Cheng Huang, Yu‐Ju Ku, Jui‐Chieh Chen · 2019 · International Journal of Oncology
29. Current position of TNF-α in melanomagenesis
    Iuliana Nenu, Diana Valentina Tudor, Gabriela Adriana Filip, Ioana Bâldea · 2015 · Tumor Biology
30. Associations of C‑X‑C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer
    Xiaofan Luo, Jiandong Tai, Yuhang Zhao, Pingwei Zhao, Di Sun, Lei Wang · 2022 · Oncology Letters
31. Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer
    Joanna Motyka, Ewa Gacuta, Aleksandra Kicman, Monika Kulesza, Paweł Ławicki, Sławomir Ławicki · 2022 · Journal of Clinical Medicine
32. New Insights into the Impact of Human Papillomavirus on Oral Cancer in Young Patients: Proteomic Approach Reveals a Novel Role for S100A8
    Marisol Miranda Galvis, Carolina Carneiro Soares, Carolina Moretto Carnielli, Jaqueline Ramalho Buttura, Raísa Sales de Sá, Estela Kaminagakura, Fábio Albuquerque Marchi, Adriana Franco Paes Leme, Clóvis Antônio Lopes Pinto, Alan Roger Santos‐Silva et al. · 2023 · Cells
33. Radiation-Induced Innate Neutrophil Response in Tumor Is Mediated by the CXCLs/CXCR2 Axis
    Faya Zhang, Oscar Mulvaney, Erica Salcedo, Subrata Manna, James Z. Zhu, Tao Wang, Chul Woo Ahn, Laurentiu M. Pop, Raquibul Hannan · 2023 · Cancers
34. CD24 promotes metastasis and chemoresistance by directly targeting Arf6-ERK pathway in esophageal squamous cell carcinoma
    Pan Hong, Tao‐Yang Xu, Jiaojiao Xu, Wenyou Chen, Jiaojiao Xu, Jindong Chen, Lan Li, Cancan Zheng, Lan Li, Jun Liu et al. · 2024 · Cancer Letters
35. Regulatory function of glycolysis-related lncRNAs in tumor progression: Mechanism, facts, and perspectives
    Xinyi Peng, Shuhao Li, Anqi Zeng, Linjiang Song · 2024 · Biochemical Pharmacology
36. Senescent cells promote breast cancer cells motility by secreting GM-CSF and bFGF that activate the JNK signaling pathway
    Nan Wang, Yan Fang, Yigong Hou, Dongmei Cheng, Emily Van Meter Dressler, Hao Wang, Juan Wang, Guanwen Wang, Yilei Li, Hong Liu et al. · 2024 · Cell Communication and Signaling
37. Immune Regulation of the Metastatic Process
    Álvaro de Mingo Pulido, Brian Ruffell · 2016 · Advances in cancer research
38. CD33+ Immature Myeloid Cells Critically Predict Recurrence in Advanced Gastric Cancer
    Takafumi Soeno, Hiroshi Katoh, Satoru Ishii, Hideki Ushiku, Kei Hosoda, Naoki Hiki, Masahiko Watanabe, Keishi Yamashita · 2019 · Journal of Surgical Research
39. Metastatic Breast Cancer, Organotropism and Therapeutics: A Review
    Ajaz Ahmad Waza, Najeebul Tarfeen, Sabhiya Majid, Yasmeena Hassan, Rashid Mir, Mohd Younis Rather, Naseer Ue Din Shah · 2021 · Current Cancer Drug Targets
40. A developmentally prometastatic niche to hepatoblastoma in neonatal liver mediated by the Cxcl1/Cxcr2 axis
    Li Fan, Qingfei Pan, Wentao Yang, Selene C. Koo, Cheng Lin Tian, Liyuan Li, Meifen Lu, Anthony Ray Brown, Bensheng Ju, John B. Easton et al. · 2022 · Hepatology
41. T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker
    Constantin N. Baxevanis, Angelos D. Gritzapis, Ioannis F. Voutsas, Panagiota Batsaki, Maria Goulielmaki, Maria Adamaki, Vassilios Zoumpourlis, Sotirios P. Fortis · 2022 · Cancers
42. Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939
    Elena A. Pudova, Anastasiya A. Kobelyatskaya, Irina Katunina, Anastasiya V. Snezhkina, K. М. Nyushko, Maria Fedorova, Vladislav Pavlov, Elizaveta V. Bulavkina, Alexandra A. Dalina, Sergey Yu. Tkachev et al. · 2022 · International Journal of Molecular Sciences
43. Stuck in the middle of chemoresistance and metastasis
    M. Teresa Villanueva · 2012 · Nature Reviews Clinical Oncology
44. Cancer derived peptide of vacuolar ATPase ‘a2’ isoform promotes neutrophil migration by autocrine secretion of IL-8
    Safaa Abdel-Salam Ibrahim, Arpita Kulshrestha, Gajendra Kumar Katara, Magdy Aly Amin, Kenneth D. Beaman · 2016 · Scientific Reports
45. Evidence for the in vivo safety of insulated foamy viral vectors
    Diana L. Browning, Elizabeth M. Everson, David J. Leap, Jonah D. Hocum, H Wang, George Stamatoyannopoulos, G D Trobridge · 2016 · Gene Therapy
46. Growth‐regulated oncogene‐α from oral submucous fibrosis fibroblasts promotes malignant transformation of oral precancerous cells
    Mei‐Yin Ye, Meng‐Yen Chen, Ya‐Han Chang, Jehn‐Shyun Huang, Tze‐Ta Huang, Tung‐Yiu Wong, Tse-Ming Hong, Yuh‐Ling Chen · 2018 · Journal of Oral Pathology and Medicine
47. Murine Macrophages Modulate Their Inflammatory Profile in Response to Gas Plasma-Inactivated Pancreatic Cancer Cells
    Aydar Khabipov, Eric Freund, Kim Rouven Liedtke, André Käding, Janik Riese, Julia van der Linde, Stephan Kersting, Lars-Ivo Partecke, Sander Bekeschus · 2021 · Cancers
48. The Role of the Microenvironment in Tumor Initiation, Progression, and Metastasis
    Cyrus Michael Ghajar, Ana Luísa Correia, Mina J. Bissell · 2015 · Elsevier eBooks
49. Immune cells in residual disease and recurrence
    Yasemin Ceyhan, Nina Marie G. Garcia, James V. Alvarez · 2023 · Trends in cancer
50. Targeting Myeloid-Derived Suppressor Cell Trafficking as a Novel Immunotherapeutic Approach in Microsatellite Stable Colorectal Cancer
    Benny Johnson · 2023 · Cancers
51. Tumor Cell-Associated IL-1α Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment
    Mathumathi Krishnamohan, Irena Kaplanov, Sapir Maudi-Boker, Muhammad Yousef, Noy Machluf-Katz, Idan Cohen, Moshe Elkabets, Jaison Titus, Marina Bersudsky, Ron N. Apte et al. · 2024 · International Journal of Molecular Sciences
52. THSD4 promotes hair growth by facilitating dermal papilla and hair matrix interactions
    Miaomiao Wang, Mengyue Wang, Jingwei Jiang, Ke Li, Huan Liang, Nian'ou Wang, Yi Zou, Dehuan Wang, Siyi Zhou, Yuchun Tang et al. · 2025 · Theranostics
53. The S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells
    Tein-Ming Yuan, Ruei‐Yue Liang, Nai‐Wan Hsiao, Show‐Mei Chuang · 2014 · Oncology Reports
54. MEGF11 is related to tumour recurrence in triple negative breast cancer via chemokine upregulation
    Jen‐Hwey Chiu, Ling‐Ming Tseng, Tzu‐Ting Huang, Chun‐Yu Liu, Jir‐You Wang, Ching-Po Huang, Yi‐Fang Tsai, Chih‐Yi Hsu · 2020 · Scientific Reports
55. Searching for Goldilocks: How Evolution and Ecology Can Help Uncover More Effective Patient-Specific Chemotherapies
    Derek S. Park, Kimberly A. Luddy, Mark Robertson‐Tessi, Cliona O’Farrelly, Robert A. Gatenby, Alexander R.A. Anderson · 2020 · Cancer Research
56. Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKCδ and PKCε activators
    Nuray Erin, Esra Tavşan, Özlem Akdeniz, Vera M. S. Isca, Patrícia Mendonca Rijo · 2021 · Cytokine
57. Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Ulcerative Colitis
    Zian Chen, Yufeng Sun, Quan-Xu Wang, Huihui Ma, Zhizhao Ma, Chuan‐Jie Yang · 2021 · Frontiers in Genetics
58. Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies
    Chintan Bhavsar, Munira M. Momin, Tabassum Asif Khan, Abdelwahab Omri · 2018 · Expert Opinion on Drug Delivery
59. Novel adherent CD11b+ Gr-1+ tumor-infiltrating cells initiate an immunosuppressive tumor microenvironment
    takuya tsubaki, Tetsuya Kadonosono, Shimon Sakurai, Tadashi Shiozawa, Toshiki Goto, Shiori Sakai, Takahiro Kuchimaru, Takeharu Sakamoto, Hitomi Watanabe, Gen Kondoh et al. · 2018 · Oncotarget
60. CXCR2 Inhibition in Pancreatic Cancer: Opportunities for Immunotherapy?
    Jennifer P. Morton, Owen James Sansom · 2016 · Immunotherapy
61. Immunological and pathological characteristics of brain parenchymal and leptomeningeal metastases from non-small cell lung cancer
    Cheng Zhou, Shu Shan, Lei Wen, Da Liu, Changguo Shan, Xin Jin, Zhaoming Zhou, Hainan Li, Juan Li, Luyue Wang et al. · 2025 · Cell Discovery
62. Sex-Based Differences in the Tumor Microenvironment
    Vincent Wuidar, Lionel Gillot, Isabelle Dias Da Silva, Alizée Lebeau, Anne Gallez, Christel Péqueux · 2021 · Advances in experimental medicine and biology
63. In vitro models of breast cancer bone metastasis: analyzing drug resistance through the lens of the microenvironment
    Anaïs Lamouline, Simone Bersini, Matteo Moretti · 2023 · Frontiers in Oncology
64. Target genes involved in antiproliferative effect of modified ginseng extracts in lung cancer A549 cells
    Keun-Hong Kim, Ilsan Choi, Yeon-Weol Lee, Chong-Kwan Cho, Hwa-Seung Yoo, Seung-Bae Lee, Suk Ho Choi, Ki-Rok Kwon, Jun‐Hyeog Jang · 2014 · Acta Biochimica et Biophysica Sinica
65. Chrono-Pharmaceutical Approaches to Optimize Dosing Regimens Based on the Circadian Clock Machinery
    Satoru Koyanagi · 2021 · Biological and Pharmaceutical Bulletin
66. Syntaxin4-Munc18c Interaction Promotes Breast Tumor Invasion and Metastasis by Regulating MT1-MMP Trafficking
    Megan I. Brasher, Shawn C. Chafe, Paul C. McDonald, Oksana Nemirovsky, Genya Gorshtein, Zachary J. Gerbec, Wells S. Brown, Olivia R. Grafinger, Matthew Marchment, Esther Matus et al. · 2021 · Molecular Cancer Research
67. Chronic liver inflammation and hepatocellular carcinogenesis are independent of S 100 A 9
    Aurora De Ponti, Lars Wiechert, Ana Stojanovic, Thomas Longerich, Silke Marhenke, Nancy Hogg, Arndt Vogel, Adelheid Cerwenka, Peter Schirmacher, Jochen Heß et al. · 2014 · International Journal of Cancer
68. Promoter Hypermethylation of CHODL Contributes to Carcinogenesis and Indicates Poor Survival in Patients with Early-stage Colorectal Cancer
    Xinyue Zhang, Kaiming Wu, Yuhua Huang, Lixia Xu, Xiaoxing Li, Ning Zhang · 2020 · Journal of Cancer
69. Overview of Basic Immunology and Clinical Application
    Bettzy Stephen, Joud Hajjar · 2020 · Advances in experimental medicine and biology
70. Guanine nucleotide binding protein like-1 (GNL1) promotes cancer cell proliferation and survival through AKT/p21 CIP1 signaling cascade
    Rehna Krishnan, Mariappan Murugiah, Naga Padma Lakshmi, Sundarasamy Mahalingam · 2020 · Molecular Biology of the Cell
71. Spatiotemporal dynamics of tumor-associated neutrophils: bridging the gap between cancer progression and immunotherapy
    Xiangyuan Chu, Junying Ma, Shihua Li, Meng Wang, Yu Tian, Chao Lv · 2026 · Molecular Cancer
72. Reversing Chemokine/Chemokine Receptor Mismatch to Enhance the Antitumor Efficacy of CAR-T Cells
    Pengfei Zhang, Chuang Wang, Le Zhang, Qiu Li · 2022 · Immunotherapy
73. Exploring the evolution of T cell function and diversity across different stages of non-small cell lung cancer
    Cheng‐Yu Chang · 2024 · American Journal of Cancer Research
74. Naive primary neutrophils play a dual role in the tumor microenvironment
    Kehinde Adebayo Babatunde, Rupsa Datta, Nathan W. Hendrikse, José María Ayuso, Anna Huttenlocher A, Melissa C. Skala, David J. Beebe, Sheena C. Kerr · 2024 · iScience
75. Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
    Maryam Sadri, Alireza Najafi, Ali R. Rahimi, Nafiseh Behranvand, Mohammad Hossein Kazemi, Hossein Khorramdelazad, Reza Falak · 2023 · International Immunopharmacology
76. A Pharmacological Strategy Using Stemofoline for more Efficacious Chemotherapeutic Treatments Against Human Multidrug Resistant Leukemic Cells
    Sonthaya Umsumarng, Sariya Mapoung, Supachai Yodkeeree, Stephen G. Pyne, Pornngarm Limtrakul · 2018 · Asian Pacific Journal of Cancer Prevention
77. CXCL1 promoted the migration and invasion abilities of oral cancer cells and might serve as a promising marker of prognosis in tongue cancer
    Shuning Zhang, Yuqing Dong, Shuangyuan Zhao, Fei Bi, Ming Xuan, Guiquan Zhu, Weihua Guo, Zhuang Zhang · 2023 · Journal of Oral Pathology and Medicine
78. Shc3 facilitates breast cancer drug resistance by interacting with ErbB2 to initiate ErbB2 / COX2 / MDR1 axis
    Yun Liu, Fang Cao, Fantong Xia, Jie Li, Xiaobao Dong, Yan Hua Guo, Jun Zhang, Qiang Zhao, Yuanyuan Liu · 2023 · Cancer Medicine
79. Differential innate immune cell signatures and effects regulated by toll-like receptor 4 during murine lung tumor promotion
    Carla‐Maria Alexander, Ka-Na Xiong, Kalpana Velmurugan, Julie Xiong, Ross S. Osgood, Alison K. Bauer · 2016 · Experimental Lung Research
80. Fluorescent glycan nanoparticle-based FACS assays for the identification of genuine drug-resistant cancer cells with differentiation potential
    Chenglong Wang, Wencai Guan, Rong Chen, Yael Levi‐Kalisman, Yichun Xu, Liwen Zhang, Min Zhou, Guoxiong Xu, Hongjing Dou · 2020 · Nano Research
81. Cancer Cell-Derived PDGFB Stimulates mTORC1 Activation in Renal Carcinoma
    Asmaa Y. Abuhamad, Nurul Nadia Mohamad Zamberi, Sakari Vanharanta, Siti Nur Hasanah Mohd Yusuf, M. Aiman Mohtar, Saiful Effendi Syafruddin · 2023 · International Journal of Molecular Sciences
82. S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models
    Lauren R. Begg, Adrienne M. Orriols, Μαρκέλλα Ζαννίκου, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F. Dunne, Sanjeev Balakrishnan, Roman Camarda et al. · 2024 · Communications Medicine
83. The role of surgical tissue injury and intraoperative sympathetic activation in postoperative immunosuppression after breast-conserving surgery versus mastectomy: a prospective observational study
    Lotte M. C. Jacobs, Leonie S. Helder, Kim I. Albers, Josephine Kranendonk, Christiaan Keijzer, Leo A. B. Joosten, Luc J. A. Strobbe, Michiel C. Warlé · 2024 · Breast Cancer Research
84. FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer
    Yifan Tai, Angela Chow, Seo-Young Han, Courtney Coker, Wanchao Ma, Yifan Gu, Valeria Estrada Navarro, Manoj Kandpal, Hanina H. Hibshoosh, Kevin M. Kalinsky et al. · 2024 · EMBO Molecular Medicine
85. Neutrophils in cancer drug resistance: Roles and therapeutic opportunities
    Hao Liu, Hongyu Zhao, Mingzhen Zhou, Xiaodi Zhao, Yuanyuan Lu · 2024 · Cancer Letters
86. Identification and validation of KIF20A for predicting prognosis and treatment outcomes in patients with breast cancer
    Mei Yang, Hui Huang, Yan Zhang, Yiping Wang, Junhao Zhao, Peiyao Lee, Yuhua Ma, Shaohua Qu · 2024 · Scientific Reports
87. Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis
    Qianying Zuo, Yibin Kang · 2025 · Advances in experimental medicine and biology
88. Screening candidate microRNA‐mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis
    Penggao Dai, Yancheng He, Guosong Luo, Jiaqi Deng, Nan Jiang, Tingting Fang, Yujuan Li, Ying Cheng · 2019 · Journal of Cellular Biochemistry
89. ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer
    Anna C. Nagel, Marta Popęda, Anna Muchlińska, Rafał Sądej, Jolanta Szade, Jacek Zieliński, Jarosław Skokowski, Magdalena Niemira, Adam Jacek Kretowski, Aleksandra Markiewicz et al. · 2022 · Cancers
90. Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast Cancer Cells
    Romain J. Amante, Priska Auf der Maur, Veronica Richina, Atul Sethi, Vytautas Iešmantavičius, Débora Bonenfant, Nicola Aceto, Mohamed Bentires‐Alj · 2022 · Journal of Mammary Gland Biology and Neoplasia
91. CUL4B functions as a tumor suppressor in KRAS-driven lung tumors by inhibiting the recruitment of myeloid-derived suppressor cells
    Xiaochen Liu, Fei Tian, Jianfeng Cui, Li Gong, Lu Xiang, Bowen Fan, Shuangteng Liu, Jiafeng Zhan, Yadi Zhou, Baichun Jiang et al. · 2023 · Oncogene
92. Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils
    Xie, Ye, Yao, Jia, Yan, Mengchao, Lin, Yan, Wei, Jiayun, Wang, Haiping, Mao, Yongcui, Liu, Pinyan, Li, Xun · 2023 · Journal of Translational Medicine
93. Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer
    Sanghoon Lee, Youngbin Cho, Yi-Ting Li, Ru-Xuan Li, Angela W. Lau, Matthew S Laird, Daniel B Brown, Priscilla F. McAuliffe, Adrian V. Lee, S. Oesterreich et al. · 2024 · Oncoimmunology
94. AP-2γ Is Required for Maintenance of Multipotent Mammary Stem Cells
    Vivian W. Gu, Edward Cho, Dakota T. Thompson, Victoria C. Cassady, Nicholas C. Borcherding, Kelsey E. Koch, Vincent T. Wu, Allison W. Lorenzen, Dana M. van der Heide, Jeffrey R. White et al. · 2020 · Stem Cell Reports
95. Irradiation-Induced Activated Microglia Affect Brain Metastatic Colonization of NSCLC Cells via miR-9/CDH1 Axis
    Yu Tong Jin, Yalin Kang, Xiaohong Peng, Li Yang, Qianxia Li, Qi Mei, Xinyi Chen, Guangyuan Hu, Yang Tang, Xianglin Yuan · 2021 · OncoTargets and Therapy
96. Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes
    Dylan Z. Dieters‐Castator, Paola Marino Dantônio, Matt Piaseczny, Guihua Zhang, Jiahui Liu, Miljan Kuljanin, Stephen E. Sherman, Michael Jewer, Katherine Quesnel, Eun Young Kang et al. · 2021 · Neoplasia
97. CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple‐Negative Breast Cancer
    Xinle Han, Jun Du, Ya-dan Zheng, Jiajing Dai, Su-Wen Lin, Bingyue Zhang, Fubo Zhong, Zhe-guang Lin, Shuqi Jiang, Wei Wei et al. · 2021 · BioMed Research International
98. Chemokine (C-X-C motif) ligand 1 maintains the immune surveillance function of natural killer cells via the PDK2/mTOR signaling pathway
    Xiaokang Zeng, Xinhuai Dong, Yanning Ma, Jie Yao · 2022 · Cell Biology and Toxicology
99. Methionine enkephalin suppresses lung cancer metastasis by regulating the polarization of tumor-associated macrophages and the distribution of myeloid-derived suppressor cells in the tumor microenvironment and inhibiting epithelial-mesenchymal transition
    Shuling Zhang, Jin Geng, Fengping Shan, Yuanye Shan, Noreen Griffin, Bin Wu, Xu Wang · 2023 · International Immunopharmacology
100. The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism
     Qing-Ling Yang, Lingyu Zhang, Haifeng Wang, Yu Li, Yueyue Wang, Tian-Tian Chen, Meng-Fen Dai, Haihua Wu, Sulian Chen, Wenrui Wang et al. · 2017 · Oncotarget